These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 2543347)

  • 1. In vivo and in vitro release of lipoprotein lipase and hepatic lipase by low molecular weight heparins.
    Meraihi Z; Lutz O; Frey A; Bach AC
    Arch Int Pharmacodyn Ther; 1989; 297():286-93. PubMed ID: 2543347
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lipoprotein lipase, hepatic lipase and plasma lipolytic activity. Effects of heparin and a low molecular weight heparin fragment (Fragmin).
    Persson E
    Acta Med Scand Suppl; 1988; 724():1-56. PubMed ID: 2843005
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Release of lipoprotein lipase and hepatic lipase activities. Effects of heparin and a low molecular weight heparin fragment.
    Persson E; Nilsson-Ehle P
    Scand J Clin Lab Invest; 1990 Feb; 50(1):43-9. PubMed ID: 2156335
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of growth hormone on lipoprotein lipase and hepatic lipase.
    Oscarsson J; Ottosson M; Edén S
    J Endocrinol Invest; 1999; 22(5 Suppl):2-9. PubMed ID: 10442563
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Plasma kinetics of lipoprotein lipase and hepatic lipase activities induced by heparin and a low molecular weight heparin fragment.
    Persson E; Nordenström J; Nilsson-Ehle P
    Scand J Clin Lab Invest; 1987 Apr; 47(2):151-5. PubMed ID: 3576117
    [TBL] [Abstract][Full Text] [Related]  

  • 6. New aspects on heparin and lipoprotein metabolism.
    Olivecrona T; Bengtsson-Olivecrona G; Ostergaard P; Liu G; Chevreuil O; Hultin M
    Haemostasis; 1993 Mar; 23 Suppl 1():150-60. PubMed ID: 8388350
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interaction of size-fractionated heparins with lipoprotein lipase and hepatic lipase in the rat.
    Liu G; Hultin M; Ostergaard P; Olivecrona T
    Biochem J; 1992 Aug; 285 ( Pt 3)(Pt 3):731-6. PubMed ID: 1497611
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A single bolus of a low molecular weight heparin to patients on haemodialysis depletes lipoprotein lipase stores and retards triglyceride clearing.
    Näsström B; Stegmayr B; Gupta J; Olivecrona G; Olivecrona T
    Nephrol Dial Transplant; 2005 Jun; 20(6):1172-9. PubMed ID: 15797889
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Depletion of lipoprotein lipase after heparin administration.
    Chevreuil O; Hultin M; Ostergaard P; Olivecrona T
    Arterioscler Thromb; 1993 Oct; 13(10):1391-6. PubMed ID: 8399074
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Release of lipoprotein lipase and hepatic triglyceride lipase in rats by heparin and other sulphated polysaccharides.
    Williams SP; Johnson EA
    Thromb Res; 1989 Aug; 55(3):361-8. PubMed ID: 2571200
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of heparin and low molecular weight heparin on lipid transport during parenteral feeding in the rat.
    Roth B; Ekelund M; Fan BG; Ekstrom U; Nilsson-Ehle P
    Acta Anaesthesiol Scand; 1996 Jan; 40(1):102-11. PubMed ID: 8904267
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacological activities of heparins obtained from different tissues: enrichment of heparin fractions with high lipoprotein lipase, antihemolytic and anticoagulant activities by molecular sieving and antithrombin III affinity chromatography.
    Bianchini P; Osima B; Parma B; Nader HB; Dietrich CP
    J Pharmacol Exp Ther; 1982 Feb; 220(2):406-10. PubMed ID: 7057400
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Release of lipoprotein lipase from cardiac myocytes by low-molecular weight heparin.
    Braun JE; Severson DL
    Lipids; 1993 Jan; 28(1):59-61. PubMed ID: 8383273
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The anticoagulant, hepatic lipase-releasing and lipoprotein lipase-releasing activities of several natural and chemically modified heparins differ.
    Pescador R; Porta R; Niada R; Diamantini G; Fedeli G; Mantovani M
    Biochem Pharmacol; 1987 Jan; 36(2):253-7. PubMed ID: 3814169
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Heparin-decasaccharides impair the catabolism of chylomicrons.
    Chevreuil O; Hultin M; Ostergaard P; Olivecrona T
    Biochem J; 1996 Dec; 320 ( Pt 2)(Pt 2):437-44. PubMed ID: 8973550
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Lipolytic and anticoagulant activities of heparin and one of its low molecular weight derivatives].
    Millot F; Bara L; Etienne J; Samama M; Laruelle P
    Nouv Rev Fr Hematol (1978); 1987; 29(6):397-400. PubMed ID: 2837726
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intravascular release and urinary excretion of tissue factor pathway inhibitor during heparin treatment.
    Brodin E; Svensson B; Paulssen RH; Nordoy A; Hansen JB
    J Lab Clin Med; 2004 Nov; 144(5):246-53; discussion 226-7. PubMed ID: 15570242
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The lipoprotein lipase system: new understandings.
    Tan MH
    Can Med Assoc J; 1978 Mar; 118(6):675-80. PubMed ID: 207404
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Simplified analysis of lipoprotein lipase activity: evaluation of lipasemic activity of low molecular weight heparin in rats.
    Jee JP; Nam SH; Park Y; Lee HJ; Park Y; Maeng HJ; Kim CK
    Arch Pharm Res; 2012 Jun; 35(6):1107-14. PubMed ID: 22870821
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of heparin on the uptake of lipoprotein lipase in rat liver.
    Neuger L; Vilaró S; Lopez-Iglesias C; Gupta J; Olivecrona T; Olivecrona G
    BMC Physiol; 2004 Nov; 4(1):13. PubMed ID: 15544705
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.